Sun, May 19, 2013
A A A
Welcome Guest
Free Trial RSS
New! Family Office and Investor Database with 11,750 contacts
Industry Updates

Barclay Hedge Fund Index down 0.44% in April, remains up 5.05% YTD

Friday, May 18, 2012
Opalesque Industry Update – Hedge funds lost 0.44% in April 2012, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index remains up 5.05% year-to-date.

“Equity markets in the US, Europe, and Japan traded lower on the month, giving back some of their Q1 profits,” says Sol Waksman, founder and president of BarclayHedge.

“While an economic slowdown in Europe stokes concerns of recession, a growing consensus that quantitative easing in the US is coming to an end confounds investors as to the impact on equity prices.”

In April, 12 of Barclay’s 18 hedge fund indices had losses. The Technology Index was down 1.59%, Pacific Rim Equities lost 1.55%, and Equity Long Bias gave up 0.79%.

On the positive side, the Barclay Equity Short Bias Index jumped 3.61% in April, the Healthcare & Biotechnology Index gained 0.60%, and Fixed Income Arbitrage was up 0.53%.

“Bond prices rose during the month, as evidenced by a 0.68 percent gain in the J.P. Morgan World Government Bond Index. The US 10-year gained more than two percent,” says Waksman.

Equity Short Bias is still the only losing hedge fund strategy in 2012. The Barclay Equity Short Bias Index was down 13.58% at the end of April.

“The steady rise of the S&P 500 has offered very limited trading opportunities for short sellers in 2012,” says Waksman. “But after three straight months of losses, equity short bias traders did manage to catch a bounce in April.”

The Barclay Fund of Funds Index lost 0.33% in April, but remains up 3.07% year-to-date.

Click here to view five years of Barclay Hedge Fund Index data, or download 14 years of monthly data.

(press release)

BarclayHedge was founded in 1985 and actively tracks more than 6,200 hedge funds, funds of hedge funds, and managed futures programs. Each month Barclay provides updated performance rankings for 38 Hedge Fund categories, 16 CTA categories, and 7 UCITS categories.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Banner
Today's Exclusives Today's Other Voices Banner More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing
  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Goldman offers hedge funds to the 99%[more]

    From TheStreet.com: Goldman Sachs said Thursday it is bringing the sophisticated trading strategies of Wall Street hedge funds to individual investors with investment portfolio's and retirement accounts as small as $1000. The bank's investment management unit, Goldman Sachs Asset Management, i

  2. Opalesque Exclusive: New research examines quantitative trend following as an equity risk hedge[more]

    Bailey McCann, Opalesque New York: New research from Nigol Koulajian founder and CIO, and Paul Czkwianianc, Head of Research at Quest Partners, a New York-based systematic fund, looks at how quantitative trend following could be used

  3. People – Jupiter switches lead manager on alternative UCITS fund, Dr. Dermot F Smurfit appointed as Chairman of the ML Capital Group[more]

    Jupiter switches lead manager on alternative UCITS fund From Citywire.co.uk: Jupiter has named Mike Buhl-Nielsen as lead manager on its Europe-focused long/short equity fund, the asset management company has announced… Full article:

  4. Launches – Blackstone preparing launch of ‘super’ hedge fund, Paulson said to team with insurer for new low-tax merger fund[more]

    Blackstone preparing launch of ‘super’ hedge fund From FT.com: Blackstone is preparing to launch a “super” hedge fund to cherry-pick the best trades from the hundreds of third-party hedge funds it invests with, in an effort to try to recapture the outsize returns the $2tn industry was on

  5. Due diligence - an in-depth medical analysis: Thus far, it has been actuarial analysis that has largely been relied upon to steer the decision making process. However, the medical data utilised in such analysis may be incomplete, rendering the conclusions drawn probably worthless.